109 related articles for article (PubMed ID: 17023046)
21. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
[TBL] [Abstract][Full Text] [Related]
22. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism in nucleotide excision repair gene XPC correlates with bleomycin-induced chromosomal aberrations.
Laczmanska I; Gil J; Karpinski P; Stembalska A; Trusewicz A; Pesz K; Ramsey D; Schlade-Bartusiak K; Blin N; Sasiadek MM
Environ Mol Mutagen; 2007 Oct; 48(8):666-71. PubMed ID: 17685459
[TBL] [Abstract][Full Text] [Related]
24. [Study on polymorphisms in metabolic enzyme genes, DNA repair genes and individual susceptibility to childhood leukemia].
Zhu R; Xia Z
Wei Sheng Yan Jiu; 2004 Sep; 33(5):635-8. PubMed ID: 15612500
[TBL] [Abstract][Full Text] [Related]
25. MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea.
Moon HW; Kim TY; Oh BR; Min HC; Cho HI; Bang SM; Lee JH; Yoon SS; Lee DS
Leuk Res; 2007 Sep; 31(9):1213-7. PubMed ID: 17156840
[TBL] [Abstract][Full Text] [Related]
26. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.
Kim HN; Lee IK; Kim YK; Tran HT; Yang DH; Lee JJ; Shin MH; Park KS; Shin MG; Choi JS; Kim HJ
Br J Haematol; 2008 Feb; 140(3):287-94. PubMed ID: 18042267
[TBL] [Abstract][Full Text] [Related]
27. Folate pathway genetic polymorphisms and susceptibility of central nervous system tumors in Thai children.
Sirachainan N; Wongruangsri S; Kajanachumpol S; Pakakasama S; Visudtibhan A; Nuchprayoon I; Lusawat A; Phudhicharoenrat S; Shuangshoti S; Hongeng S
Cancer Detect Prev; 2008; 32(1):72-8. PubMed ID: 18406541
[TBL] [Abstract][Full Text] [Related]
28. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis.
Pereira TV; Rudnicki M; Pereira AC; Pombo-de-Oliveira MS; Franco RF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1956-63. PubMed ID: 17035405
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population.
Rouissi K; Ouerhani S; Oliveira E; Marrakchi R; Cherni L; Ben Othman F; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; Prata MJ; Benammar Elgaaied A
Cancer Genet Cytogenet; 2009 Nov; 195(1):43-53. PubMed ID: 19837268
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Kyriacou K; Hadjisavvas A
Breast Cancer Res Treat; 2008 Dec; 112(3):575-9. PubMed ID: 18188695
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers.
Ryk C; Kumar R; Thirumaran RK; Hou SM
Lung Cancer; 2006 Dec; 54(3):285-92. PubMed ID: 17034901
[TBL] [Abstract][Full Text] [Related]
34. Aberrations in folate metabolic pathway and altered susceptibility to autism.
Mohammad NS; Jain JM; Chintakindi KP; Singh RP; Naik U; Akella RR
Psychiatr Genet; 2009 Aug; 19(4):171-6. PubMed ID: 19440165
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.
Unal M; Güven M; Batar B; Ozaydin A; Sarici A; Devranoğlu K
Exp Eye Res; 2007 Sep; 85(3):328-34. PubMed ID: 17637462
[TBL] [Abstract][Full Text] [Related]
36. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors.
Krull KR; Brouwers P; Jain N; Zhang L; Bomgaars L; Dreyer Z; Mahoney D; Bottomley S; Okcu MF
J Pediatr; 2008 Jan; 152(1):101-5. PubMed ID: 18154909
[TBL] [Abstract][Full Text] [Related]
37. [Childhood leukemia: a genetic disease!].
Sinnett D; N'Diaye N; St-Onge P; Healy J
Med Sci (Paris); 2007 Nov; 23(11):968-74. PubMed ID: 18021709
[TBL] [Abstract][Full Text] [Related]
38. Enzyme polymorphisms influencing the metabolism of heterocyclic aromatic amines.
Airoldi L; Magagnotti C; Pastorelli R; Fanelli R
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 802(1):175-81. PubMed ID: 15036009
[TBL] [Abstract][Full Text] [Related]
39. Genetic variations in multiple myeloma I: effect on risk of multiple myeloma.
Vangsted A; Klausen TW; Vogel U
Eur J Haematol; 2012 Jan; 88(1):8-30. PubMed ID: 21883480
[TBL] [Abstract][Full Text] [Related]
40. Metabolic enzyme polymorphisms and susceptibility to acute leukemia in adults.
Morgan GJ; Smith MT
Am J Pharmacogenomics; 2002; 2(2):79-92. PubMed ID: 12083944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
